|1.||Hou, Jiajie: 7 articles (08/2015 - 02/2013)|
|2.||Sun, Beicheng: 7 articles (08/2015 - 02/2013)|
|3.||Motiwala, Tasneem: 7 articles (08/2013 - 09/2003)|
|4.||Jacob, Samson T: 7 articles (08/2013 - 09/2003)|
|5.||Kutay, Huban: 5 articles (12/2011 - 09/2004)|
|6.||Jiang, Runqiu: 4 articles (08/2015 - 02/2013)|
|7.||Huang, Xingxu: 4 articles (08/2015 - 02/2013)|
|8.||Roy, Satavisha: 4 articles (08/2013 - 02/2009)|
|9.||Ghoshal, Kalpana: 4 articles (08/2013 - 09/2003)|
|10.||Deng, Lei: 3 articles (08/2015 - 02/2013)|
08/01/2015 - "In this study, we aimed to investigate the role of truncated isoform of protein tyrosine phosphatase receptor-type O (PTPROt) in T cell-mediated anti-tumor immunity. "
04/20/2015 - "Protein tyrosine phosphatase receptor type O (PTPRO) was recently identified as a tumor suppressor, but little is known about its role in NASH. "
01/01/2014 - "Epigenetic inactivation of the protein tyrosine phosphatase receptor-type O gene (PTPRO) has been described in several types of cancer. "
08/21/2013 - "Inhibiting the inhibitor: targeting vascular endothelial protein tyrosine phosphatase to promote tumor vascular maturation."
01/01/2013 - "Protein Tyrosine Phosphatase Receptor-type O (PTPRO) has recently been in the spotlight as a tumor suppressor, whose encoding gene is frequently methylated in cancers. "
|2.||Hepatocellular Carcinoma (Hepatoma)
09/21/2004 - "Previous study in our laboratory demonstrated suppression of the gene for protein tyrosine phosphatase receptor-type O (PTPRO) in primary and established rat hepatomas. "
09/25/2003 - "Suppression of the protein tyrosine phosphatase receptor type O gene (PTPRO) by methylation in hepatocellular carcinomas."
10/01/2014 - "Protein tyrosine phosphatase receptor type O (PTPRO) has been identified as a tumor suppressor in a number of cancers including hepatocellular carcinoma (HCC). "
08/01/2013 - "We have previously reported that the gene encoding protein tyrosine phosphatase receptor type-O (PTPRO) is suppressed by promoter methylation in a rat model of hepatocellular carcinoma (HCC) and it functions as tumor suppressor in leukemia and lung cancer. "
|3.||B-Cell Lymphoma (Lymphoma, B Cell)
|5.||Wilms Tumor (Wilm's Tumor)
03/01/2014 - "Expression of synaptopodin, Wilms tumor protein 1 (WT1), glomerular epithelial protein 1 (GLEPP1) and nephrin was evaluated in 52 LN biopsies by immunohistochemistry. "
09/01/1998 - "The podocyte nature of the material was confirmed by detection of podocyte-specific mRNA (glomerular epithelial protein 1 and Wilms' tumor protein 1). "
02/01/2001 - "(2) In the cellular variant, most podocytes had lost podocyte-specific epitopes (podocalyxin, synaptopodin, glomerular epithelial protein-1, Wilm's tumor protein-1, complement receptor-1, and vimentin). "
11/01/2003 - "However, a significant positive correlation between alpha-actinin-4, glomerular epithelial protein 1, synaptopodin, dystroglycan, Wilms tumor antigen 1, and nephrin was found in all analyzed glomeruli, whereas podocin mRNA expression did not correlate. "
11/01/2003 - "For identifying potential diagnostic markers of proteinuric glomerulopathies, glomerular mRNA levels of molecules relevant for podocyte function (alpha-actinin-4, glomerular epithelial protein 1, Wilms tumor antigen 1, synaptopodin, dystroglycan, nephrin, podoplanin, and podocin) were determined by quantitative real-time RT-PCR from microdissected glomeruli. "
|5.||Class 3 Receptor-Like Protein Tyrosine Phosphatases
|6.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|7.||Messenger RNA (mRNA)
|8.||tyrosine receptor (receptor, tyrosine)
|9.||6-pyruvoyltetrahydropterin synthase (PTPS)